However, experiments in the humanized models of hepatocellular carcinoma have shown that antisense oligonucleotide-mediated suppression of HAND2-AS1 exerts anti-tumor activity in a synergic manner with siRNA-mediated inhibition of BMPR1A. The gene discussed is HAND2; the disease is hepatocellular carcinoma.